Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Pink pill for women

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: D, Kaushik (JSS University, Pharmaceutics, Mysuru, India)
  • Co-author(s): Kaushik D: Pharmaceutics, JSS University, Mysuru, India
    T M Pramod Kumar: Pharmaceutics, JSS University, Mysuru, India
    Balamuralidhara V: Pharmaceutics, JSS University, Mysuru, India
    Manish Kumar: Pharmaceutics, JSS University, Mysuru, India
  • Abstract:

    Backgrounds

    Flibanserin, a drug with mixed effects on serotonergic and dopaminergic neurotransmitter systems, has recently been recommended for FDA approval,with many restrictions for the treatment of low sexual desire in premenopausal women i.e. HSDD. It is contraindicated with alcohol as it may cause fainting side effects and risk of..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses